Mitsubishi Chemical to negotiate with Bain to sell drug unit

TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma, Nikkei has learned.

The deal could exceed 500 billion yen ($3.2 billion).